UPS - Concerns of chelation therapy, autism

[Guest guest]

Concerns of chelation therapy, autism

ITHACA, N.Y., Dec. 14 (UPI) -- Lead chelation therapy reduces lead exposure problems but could create lasting effects for children treated for autism, say New York researchers.

Cornell University researchers say their study in young rats has implications for the treatment of autistic children, because when rats with no lead in their systems were treated with the lead-removing chemical, they showed declines in their learning and behavior that were similar to the rats that were exposed to lead.

Chelating drugs, which bind to lead and other metals in the blood, are increasingly being used for the treatment of autism in children.

The rats with moderate lead exposure benefited greatly from the lead chelation medication succimer, and rats exposed to higher lead levels showed benefits in the emotional domain; however, for the control group with no lead exposure that were given succimer, "we found lasting cognition and emotion-regulation (deficits) that were as pervasive and large as rats with high lead exposure," according to the study published in the journal Environmental Health Perspectives.

One possibility is that succimer, in the absence of lead, may disrupt the balance of such essential minerals as zinc and iron.

"These findings raise concerns about the use of chelating agents in treating autistic children," said senior author Barbara Strupp.

[Guest guest]

Therefore lead chelation should only be done after tests show raised

lead levels. Paragraph 4 shows that in the presence of raised lead

levels chelation is beneficial. It's an odd way round to put it in the

head line. Paragraph 1 is odd because it seems to assume that children

with autism do not have raised lead levels.

Sally

Mum231ASD@... wrote:

Concerns of chelation therapy, autism

ITHACA, N.Y., Dec. 14 (UPI) -- Lead chelation therapy reduces lead

exposure problems but could create lasting effects for children treated

for autism, say New York researchers.

Cornell University researchers say their study in young rats has

implications for the treatment of autistic children, because when rats

with no lead in their systems were treated with the lead-removing

chemical, they showed declines in their learning and behavior that were

similar to the rats that were exposed to lead.

Chelating drugs, which bind to lead and other metals in the blood,

are increasingly being used for the treatment of autism in children.

The rats with moderate lead exposure benefited greatly from the

lead chelation medication succimer, and rats exposed to higher lead

levels showed benefits in the emotional domain; however, for the

control group with no lead exposure that were given succimer, "we found

lasting cognition and emotion-regulation (deficits) that were as

pervasive and large as rats with high lead exposure," according to the

study published in the journal Environmental Health Perspectives.

One possibility is that succimer, in the absence of lead, may

disrupt the balance of such essential minerals as zinc and iron.

"These findings raise concerns about the use of chelating agents

in treating autistic children," said senior author Barbara Strupp.

No virus found in this incoming message.

Checked by AVG Free Edition.

Version: 7.1.409 / Virus Database: 268.15.21/589 - Release Date: 15/12/2006

[Guest guest]

Not all our kids have raised lead levels, we don't, but I tested her all the way through the process and I didn't see any cognitive decline. Then sent her out for testing twice and the 5 learning disabilities that were present the first time were gone by the second testing. There was no loss of cognitive functioning, only growth. And unlike a lot of people who give the credit to Ala, I always noticed that dmsa did something special here.

There is a lot we don't know about this study. How much chelator was given and for how long. And I dare say rats/mice might just respond/react differently than children. The reporting of the way the actual study was done is very sketchy.

Children have been given dmsa for lead poisoning for a very, very long time so thinking if there were issues with cognitive processes and dmsa it would have surfaced long before this.

All this study says that children with lead benefit from dmsa and that if there is no lead it should not be used. Only anecdotal, but we had no lead and no cognitive decline.

Re: UPS - Concerns of chelation therapy, autism

Therefore lead chelation should only be done after tests show raised lead levels. Paragraph 4 shows that in the presence of raised lead levels chelation is beneficial. It's an odd way round to put it in the head line. Paragraph 1 is odd because it seems to assume that children with autism do not have raised lead levels.SallyMum231ASDaol wrote:

Concerns of chelation therapy, autism

ITHACA, N.Y., Dec. 14 (UPI) -- Lead chelation therapy reduces lead exposure problems but could create lasting effects for children treated for autism, say New York researchers.

Cornell University researchers say their study in young rats has implications for the treatment of autistic children, because when rats with no lead in their systems were treated with the lead-removing chemical, they showed declines in their learning and behavior that were similar to the rats that were exposed to lead.

Chelating drugs, which bind to lead and other metals in the blood, are increasingly being used for the treatment of autism in children.

The rats with moderate lead exposure benefited greatly from the lead chelation medication succimer, and rats exposed to higher lead levels showed benefits in the emotional domain; however, for the control group with no lead exposure that were given succimer, "we found lasting cognition and emotion-regulation (deficits) that were as pervasive and large as rats with high lead exposure," according to the study published in the journal Environmental Health Perspectives.

One possibility is that succimer, in the absence of lead, may disrupt the balance of such essential minerals as zinc and iron.

"These findings raise concerns about the use of chelating agents in treating autistic children," said senior author Barbara Strupp.

No virus found in this incoming message.

Checked by AVG Free Edition.

Version: 7.1.409 / Virus Database: 268.15.21/589 - Release Date: 15/12/2006